Stock 6649 TAIWAN BIOMATERIAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Taiwan Biomaterial Co., Ltd.

Equities

6649

TW0006649007

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
28.6 TWD -1.38% Intraday chart for Taiwan Biomaterial Co., Ltd. -1.89% -8.63%
Mar. 14 Taiwan Biomaterial Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Taiwan Biomaterial Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,464 1,259 980.1 818.4 1,457 1,315
Enterprise Value (EV) 1 1,035 928.4 847.5 739.7 1,193 1,071
P/E ratio -24.2 x -17 x -17.7 x -17.3 x 42 x -130 x
Yield - - - - 0.58% -
Capitalization / Revenue 1,458 x 76.1 x 54.2 x 19.6 x 11.4 x 18 x
EV / Revenue 1,031 x 56.1 x 46.9 x 17.7 x 9.37 x 14.7 x
EV / EBITDA -16.6 x -13.7 x -14.3 x -14.3 x 33.1 x -469 x
EV / FCF -21.6 x -10.6 x -3.92 x -42.1 x -19.8 x -84.7 x
FCF Yield -4.63% -9.41% -25.5% -2.38% -5.05% -1.18%
Price to Book 3.17 x 2.4 x 2.09 x 1.94 x 2.25 x 2.09 x
Nbr of stocks (in thousands) 30,000 33,000 33,000 33,000 42,000 42,000
Reference price 2 48.80 38.15 29.70 24.80 34.70 31.30
Announcement Date 3/26/19 3/26/20 3/30/21 3/21/22 3/16/23 3/14/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1.004 16.54 18.08 41.67 127.3 72.84
EBITDA 1 -62.28 -67.57 -59.18 -51.8 36.02 -2.284
EBIT 1 -67.91 -73.05 -65.11 -56.72 25.46 -14.22
Operating Margin -6,764.14% -441.59% -360.22% -136.1% 20% -19.53%
Earnings before Tax (EBT) 1 -60.54 -71.3 -55.37 -47.44 33.76 -9.031
Net income 1 -60.54 -71.3 -55.37 -47.44 33.76 -10.13
Net margin -6,029.98% -430.99% -306.31% -113.84% 26.51% -13.91%
EPS 2 -2.018 -2.246 -1.678 -1.438 0.8260 -0.2412
Free Cash Flow 1 -47.93 -87.34 -216.4 -17.57 -60.21 -12.64
FCF margin -4,773.59% -527.97% -1,196.97% -42.16% -47.29% -17.35%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - 0.2000 -
Announcement Date 3/26/19 3/26/20 3/30/21 3/21/22 3/16/23 3/14/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 429 331 133 78.7 264 243
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -47.9 -87.3 -216 -17.6 -60.2 -12.6
ROE (net income / shareholders' equity) -12.3% -14.5% -11.1% -10.6% 6.31% -1.59%
ROA (Net income/ Total Assets) -8.46% -8.07% -6.6% -6.29% 2.47% -1.22%
Assets 1 716 884 838.8 753.7 1,367 827
Book Value Per Share 2 15.40 15.90 14.20 12.80 15.40 14.90
Cash Flow per Share 2 5.970 2.390 2.150 2.780 4.360 4.090
Capex 1 3.72 89.2 149 28 35.7 2.57
Capex / Sales 370.02% 539.38% 825.01% 67.22% 28.02% 3.53%
Announcement Date 3/26/19 3/26/20 3/30/21 3/21/22 3/16/23 3/14/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Equipment

1st Jan change Capi.
TAIWAN BIOMATERIAL CO., LTD. Stock Taiwan Biomaterial Co., Ltd.
-8.63% 37.61M
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+75.69% 12.57B
PENUMBRA, INC. Stock Penumbra, Inc.
-24.68% 7.29B
MASIMO CORPORATION Stock Masimo Corporation
+6.22% 6.7B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+12.58% 5.38B
GETINGE AB Stock Getinge AB
-16.63% 4.86B
APT MEDICAL INC. Stock APT Medical Inc.
+26.90% 4.58B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-21.14% 3.74B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-22.99% 2.95B
NOVOCURE LIMITED Stock NovoCure Limited
+47.42% 2.4B
Medical Equipment
  1. Stock Market
  2. Equities
  3. 6649 Stock
  4. Financials Taiwan Biomaterial Co., Ltd.